IR-Med Inc (IRME)
0.40
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
IR-Med Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.001M |
| September 30, 2023 | -0.001M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | -0.002M |
| September 30, 2022 | -0.012M |
| Date | Value |
|---|---|
| June 30, 2022 | -0.025M |
| March 31, 2022 | -0.02M |
| December 31, 2021 | -0.027M |
| September 30, 2021 | -0.01M |
| June 30, 2021 | -0.017M |
| March 31, 2021 | -0.007M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.027M
Minimum
Dec 2021
-0.001M
Maximum
Sep 2023
-0.0122M
Average
-0.011M
Median
Cash from Investing (Quarterly) Benchmarks
| InspireMD Inc | 5.506M |
| IDenta Corp | 0.0935M |
| Pluri Inc | -4.805M |
| BiomX Inc | 0.054M |
| Raphael Pharmaceutical Inc | 0.001M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.372M |
| Cash from Financing (Quarterly) | 0.715M |
| Free Cash Flow | -2.295M |
| Free Cash Flow Per Share (Quarterly) | -0.0053 |
| Free Cash Flow Yield | -8.23% |